The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded Ursa Analytics, Inc. a $285,577 project grant to develop new unsupervised machine learning algorithms for high-throughput, label-free image analysis of chimeric antigen receptor (CAR)-T cell data. This project aims to optimize manufacturing processes for producing consistent, viable CAR-T cell therapies, which could help drive down the production costs for these complex, personalized cellular therapies. The award period is from May 15, 2024 to April 30, 2025.
Generated 1/28/25, 7:19 AM